Our Blog

hivve Celebrates Ten Years of ImpactTracker with Global Customers

hivve and h2 Software today announced a collaboration to address the global Business School sector’s need to capture impact-related data.

New Job Opening – Impact Consultant (UK)

We’re excited to announce that we are hiring for an Impact Consultant, based in the United Kingdom! Apply within.

hivve Ltd and H2 Software Ltd Announce Impact Accreditation Partnership for Business Schools

hivve and h2 Software today announced a collaboration to address the global Business School sector’s need to capture impact-related data.

REF 2029 – UK’s Research Excellence Framework (REF) Delayed from 2028

Join us and our global panels on Wednesday 1st November 2023 for the Future of Research Impact Assessment!

Impact Symposium 2023: The Future of Research Impact Assessment

Join us and our global panels on Wednesday 1st November 2023 for the Future of Research Impact Assessment!

Impact Entrepreneur: Collecting Data for Impact

In this Impact Entrepreneur article, Dr Mary Ho and Alex Smith of hivve explore why starting early on your impact data journey is critical!

RAE 2026, REF 2028 and the Evolving Trajectory of the Impact Assessment

With developments in Hong Kong’s RAE 2026 and the UK’s REF 2028, we assess some of the evolving trends worldwide for impact assessment.

hivve Completes ISO 27001 Audit

Last month hivve successfully completed its most recent ISO 27001 audit. The company first received ISO 27001 compliance in November 2021 as Vertigo Ventures.

Inside-Out vs Outside-In Impact Measurement in Impact Entrepreneur

What does it mean to be a net positive company, and are all businesses ready for it? Our article explores the different approaches.

Sheil Review Suggests New Possibilities for the Future of Research Impact Assessment in Australia

We take a look at the implications of the Sheil review of the ARC for the future of impact assessment in Australia.

Vertigo Ventures contribute to Guardian Pharma Roundtable

Vertigo Ventures contribute to Guardian Pharma Roundtable

Should companies not publish the results of all trials ever done for drugs that went into use?, asked Bokani Tshidzu, of Vertigo Ventures. Sir Peter Dixon, the chair of Diabetes UK, agreed, warning that people will not believe that drug firms have changed "until...

read more

Join our mailing list

and keep up-to-date with everything impact